• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阿托伐他汀上调PPARα/γ表达并在体外抑制心肌细胞肥大

[Atorvastatin upregulates the expression of PPAR alpha/gamma and inhibits the hypertrophy of cardiac myocytes in vitro].

作者信息

Sheng Li, Ye Ping, Liu Yong-xue

机构信息

Department of Geriatric Cardiology and Nephrology, Chinese PLA General Hospital, Beijing 100853, China.

出版信息

Zhonghua Xin Xue Guan Bing Za Zhi. 2005 Dec;33(12):1080-4.

PMID:16563274
Abstract

OBJECTIVE

To investigate the effects of atorvastatin on angiotensin II (Ang II)-induced hypertrophy of cardiac myocytes (MC) and the changes of mRNA expression of peroxisome proliferators-activated receptor alpha, gamma (PPAR alpha, gamma) subtypes in vitro.

METHODS

Hypertrophy in neonatal rat MC was established with Ang II and treated with atorvastatin. The surface area of MC was analyzed by the aid of NIH Image J software, and the synthetic rate of protein in MC was detected by (3)H-leucine incorporation. mRNA expression of atrial natriuretic peptide (ANP), brain natriuretic peptide (BNP), matrix metalloproteinase (MMP) 9, MMP2, interleukin1beta (IL-1beta) and PPARalpha, gamma was measured by reverse transcription-polymerase chain reaction (RT-PCR).

RESULTS

Changes of MC were detected induced by Ang II, including increases in surface area, mRNA expression of ANP, BNP, MMP9, MMP2 and IL-1beta, and (3)H-leucine incorporation, as well as a decrease in mRNA expression of PPARalpha, gamma. Treatment with atorvastatin inhibited the changes above in a dose-dependent manner, but no change was found in treated with DMSO.

CONCLUSION

Atorvastatin inhibits cardiac hypertrophy in vitro. It is suggested that atorvastatin has a potential role in the prevention and treatment of cardiac diseases such as cardiac hypertrophy, and PPAR alpha and gamma maybe involved in this process.

摘要

目的

研究阿托伐他汀对血管紧张素 II(Ang II)诱导的心肌细胞(MC)肥大的影响以及体外过氧化物酶体增殖物激活受体α、γ(PPARα、γ)亚型mRNA表达的变化。

方法

用Ang II诱导新生大鼠MC肥大并给予阿托伐他汀处理。借助NIH Image J软件分析MC表面积,通过³H-亮氨酸掺入法检测MC中蛋白质合成速率。采用逆转录-聚合酶链反应(RT-PCR)检测心房利钠肽(ANP)、脑利钠肽(BNP)、基质金属蛋白酶(MMP)9、MMP2、白细胞介素1β(IL-1β)以及PPARα、γ的mRNA表达。

结果

检测到Ang II诱导MC发生变化,包括表面积增加、ANP、BNP、MMP9、MMP2和IL-1β的mRNA表达增加以及³H-亮氨酸掺入增加,同时PPARα、γ的mRNA表达降低。阿托伐他汀处理以剂量依赖方式抑制上述变化,但二甲基亚砜处理未发现变化。

结论

阿托伐他汀在体外可抑制心肌肥大。提示阿托伐他汀在预防和治疗如心肌肥大等心脏疾病方面具有潜在作用,且PPARα和γ可能参与此过程。

相似文献

1
[Atorvastatin upregulates the expression of PPAR alpha/gamma and inhibits the hypertrophy of cardiac myocytes in vitro].阿托伐他汀上调PPARα/γ表达并在体外抑制心肌细胞肥大
Zhonghua Xin Xue Guan Bing Za Zhi. 2005 Dec;33(12):1080-4.
2
Peroxisome proliferator-activated receptor beta/delta activation improves angiotensin II-induced cardiac hypertrophy in vitro.过氧化物酶体增殖物激活受体β/δ的激活可改善体外血管紧张素II诱导的心肌肥大。
Clin Exp Hypertens. 2008 Feb;30(2):109-19. doi: 10.1080/10641960801945840.
3
Atorvastatin attenuating down-regulation of peroxisome proliferator-activated receptor gamma in preventing cardiac hypertrophy of rats in vitro and in vivo.阿托伐他汀在体内外预防大鼠心脏肥大过程中减轻过氧化物酶体增殖物激活受体γ的下调。
J Pharm Pharm Sci. 2006;9(3):365-75.
4
Effect of Atorvastatin on Expression of Peroxisome Proliferator-activated Receptor Beta/delta in Angiotensin II-induced Hypertrophic Myocardial Cells In Vitro.阿托伐他汀对血管紧张素II诱导的体外肥厚心肌细胞中过氧化物酶体增殖物激活受体β/δ表达的影响。
Chin Med Sci J. 2015 Dec;30(4):245-51. doi: 10.1016/s1001-9294(16)30008-6.
5
[Atorvastatin attenuates parathyroid hormone 1-34 induced cardiomyocytes hypertrophy through downregulating K-Ras-ERK1/2 pathway].阿托伐他汀通过下调K-Ras-ERK1/2信号通路减轻甲状旁腺激素1-34诱导的心肌细胞肥大
Zhonghua Xin Xue Guan Bing Za Zhi. 2012 Dec;40(12):1051-5.
6
MicroRNA-22 downregulation by atorvastatin in a mouse model of cardiac hypertrophy: a new mechanism for antihypertrophic intervention.阿托伐他汀下调小鼠心脏肥大模型中的MicroRNA-22:抗肥大干预的新机制
Cell Physiol Biochem. 2013;31(6):997-1008. doi: 10.1159/000350117. Epub 2013 Jul 2.
7
[The effect of PPARalpha signal channel on atorvastatin inhibiting MMP-9 expression in aging myocytes].[过氧化物酶体增殖物激活受体α信号通路对阿托伐他汀抑制衰老心肌细胞中基质金属蛋白酶-9表达的影响]
Zhongguo Ying Yong Sheng Li Xue Za Zhi. 2013 Sep;29(5):469-72.
8
Effect of pioglitazone on the expression of inflammatory cytokines in attenuating rat cardiomyocyte hypertrophy.吡格列酮对减轻大鼠心肌细胞肥大中炎性细胞因子表达的影响。
Methods Find Exp Clin Pharmacol. 2006 Dec;28(10):691-6. doi: 10.1358/mf.2006.28.10.1037500.
9
In vivo and in vitro protective effects of pentamethylquercetin on cardiac hypertrophy.五甲基槲皮素对心肌肥厚的体内和体外保护作用。
Cardiovasc Drugs Ther. 2012 Apr;26(2):109-20. doi: 10.1007/s10557-011-6363-z.
10
Quercetin inhibits left ventricular hypertrophy in spontaneously hypertensive rats and inhibits angiotensin II-induced H9C2 cells hypertrophy by enhancing PPAR-γ expression and suppressing AP-1 activity.槲皮素通过增强 PPAR-γ 表达和抑制 AP-1 活性抑制自发性高血压大鼠左心室肥厚,并抑制血管紧张素 II 诱导的 H9C2 细胞肥大。
PLoS One. 2013 Sep 10;8(9):e72548. doi: 10.1371/journal.pone.0072548. eCollection 2013.

引用本文的文献

1
Concomitant Administration of Rosuvastatin and Lefleunamide in Low doses Synergize Against Complete Freunds Adjuvant (CFA)-Induced Rheumatoid Arthritis in Experimental Model.低剂量瑞舒伐他汀与来氟米特联合给药对实验模型中完全弗氏佐剂(CFA)诱导的类风湿性关节炎具有协同作用。
J Pharm Res Int. 2021;33(42A):370-382. doi: 10.9734/jpri/2021/v33i42a32415. Epub 2021 Aug 30.
2
Interplay between statins and PPARs in improving cardiovascular outcomes: a double-edged sword?他汀类药物和 PPAR 之间的相互作用改善心血管结局:一把双刃剑?
Br J Pharmacol. 2012 Jan;165(2):373-9. doi: 10.1111/j.1476-5381.2011.01597.x.